Last Updated : Thursday, November 14, 2019 20:40:01

NATCO Pharma’s Vishakhapatnam Formulation facility kicks-off

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered NATCO Pharma Ltd said of having commenced commercial manufacturing operations at company’s Vishakhapatnam formulation facility.

In a press-release as submitted by the company to the Indian Bourses, titled – “Commercial Manufacturing Operations begin in NATCO’s Visakhapatnam Formulation Facility” it further read that, Natco Pharma Ltd is pleased to announce that its Finished Dosage Formulations (FDF) facility in Visakhapatnam has commenced commercial operations.


The facility is a part of the Special Economic Zone (SEZ) and intended to cater primarily to the U.S. & other international markets.

Vizag facility is a key part of NATCO’ s capacity expansion plans for its pipeline of products and diversification into different geographies.

From capability perspective, this facility will focus mostly on oral solid dosages (tablets and capsules), including a cytotoxic block for products in the oncology segment.

An application with the U.S. Food and Drug Administration (USFDA) is already filed for site transfer of the first product & to trigger a regulatory audit.


FOLLOW US ON :-

  • BLOG : http://datelinegujarat.blogspot.com/
  • FACEBOOK : https://facebook.com/dateline.gujarat
  • GOOGLE+ : https://plus.google.com/110800330482982580799
  • INSTAGRAM : https://www.instagram.com/datelinegujarat/
  • LINKEDIN : https://in.linkedin.com/in/dateline-gujarat-7681885a
  • TELEGRAM : https://t.me/DATELINEGUJARATDOTCOM
  • TWITTER : https://twitter.com/DatelineGujarat
  • YOUTUBE :  https://www.youtube.com/user/DatelineGujarat
  • WEBSITE (URL) : https://datelinegujarat.com/

Follow DATELINE GUJARAT On :-

FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


SHARE THIS NEWS ON :-

Do NOT follow this link or you will be banned from the site!